Financhill
Sell
34

GNMLF Quote, Financials, Valuation and Earnings

Last price:
$1.00
Seasonality move :
-4.17%
Day range:
$1.00 - $1.00
52-week range:
$0.93 - $1.43
Dividend yield:
4.26%
P/E ratio:
10.92x
P/S ratio:
1.05x
P/B ratio:
1.62x
Volume:
20K
Avg. volume:
5.6K
1-year change:
-30.07%
Market cap:
$973.8M
Revenue:
$1B
EPS (TTM):
$0.09

Earnings Data

Next earnings date for GNMLF
Apr 29
2026
Most recent earnings per share
$0.02
Beat by $0.02
(Oct 22/2025)
Consensus Estimate
--
(Oct 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GNMLF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $242.3M -- -- -- --
10/22/2025 Q3 $256.5M $238.4M $0.02 -- --
07/24/2025 Q2 $249.8M $239.7M $0.02 -- --
04/30/2025 Q1 $235.3M $215.9M $0.03 -- --
02/26/2025 Q4 $229.7M $232.2M $0.02 -- --
10/23/2024 Q3 $236.5M $269M $0.04 -- --
07/24/2024 Q2 $251.1M $270M $0.04 -- --
04/24/2024 Q1 $214.5M $247.1M $0.02 -- --
12/31/2023 Q4 $219.8M $200.7M -$0.00 -- --
09/30/2023 Q3 -- -- $0.02 -- --
06/30/2023 Q2 -- -- $0.02 -- --
03/31/2023 Q1 -- -- $0.02 -- --
12/31/2022 Q4 -- -- $0.02 -- --
09/30/2022 Q3 -- -- $0.02 -- --
06/30/2022 Q2 -- -- $0.02 -- --
03/31/2022 Q1 -- -- $0.02 -- --
12/31/2021 Q4 -- -- $0.01 -- --
09/30/2021 Q3 -- -- $0.02 -- --
06/30/2021 Q2 -- -- $0.02 -- --
03/31/2021 Q1 -- -- $0.02 -- --
12/31/2020 Q4 -- -- $0.01 -- --
09/30/2020 Q3 -- -- $0.02 -- --
06/30/2020 Q2 -- -- $0.02 -- --
03/31/2020 Q1 -- -- $0.02 -- --
12/31/2019 Q4 -- -- $0.00 -- --
09/30/2019 Q3 -- -- $0.01 -- --
06/30/2019 Q2 -- -- $0.01 -- --
03/31/2019 Q1 -- -- $0.01 -- --
12/31/2018 Q4 -- -- $0.01 -- --
09/30/2018 Q3 -- -- $0.01 -- --
06/30/2018 Q2 -- -- $0.02 -- --
03/31/2018 Q1 -- -- $0.02 -- --
12/31/2017 Q4 -- -- $0.02 -- --
09/30/2017 Q3 -- -- $0.01 -- --
06/30/2017 Q2 -- -- $0.01 -- --
03/31/2017 Q1 -- -- $0.02 -- --
12/31/2016 Q4 -- -- $0.00 -- --
09/30/2016 Q3 -- -- $0.02 -- --
06/30/2016 Q2 -- -- -$0.13 -- --
03/31/2016 Q1 -- -- $0.02 -- --

Genomma Lab Internacional SAB de CV Earnings Questions

  • How Much did Genomma Lab Internacional SAB de CV Generate in Revenue Last Quarter?

    Genomma Lab Internacional SAB de CV reported $238.4M worth of top line sales in its most recent quarter.

  • Did Genomma Lab Internacional SAB de CV Beat Earnings Last Quarter?

    Genomma Lab Internacional SAB de CV announced earnings per share of $0.02 which represents a beat of analyst forecast a -- per share.

  • Is Genomma Lab Internacional SAB de CV Profitable?

    Genomma Lab Internacional SAB de CV reported $152.2M that represents $0.16 per share over the last quarter.

  • What is the Analyst Consensus for Genomma Lab Internacional SAB de CV EPS Next Year?

    Genomma Lab Internacional SAB de CV's earnings are forecast to grow from $0.08 per share to -- per share next year representing an increase of --.

  • When is Genomma Lab Internacional SAB de CV's Earnings Date?

    Genomma Lab Internacional SAB de CV's next earnings date is April 29, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 38x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
59
SEZL alert for Feb 27

Sezzle, Inc. [SEZL] is down 13.92% over the past day.

Buy
83
GCT alert for Feb 27

GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.

Buy
62
LMAT alert for Feb 27

LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock